Բեռնվում է…
Clinical and virological outcomes with baloxavir compared with oseltamivir in pediatric patients aged 6 to < 12 years with influenza: an open-label, randomized, active-controlled trial protocol
BACKGROUND: Children with influenza virus infections are prone to complications and are common sources of influenza transmission. Baloxavir marboxil inhibits cap-dependent endonuclease and was approved for influenza treatment in adolescent, adult, and pediatric patients in Japan. The miniSTONE-2 stu...
Հիմնական հեղինակներ: | Ishiguro, Nobuhisa, Morioka, Ichiro, Nakano, Takashi, Furukawa, Masashi, Tanaka, Shintaro, Kinoshita, Masahiro, Manabe, Atsushi |
---|---|
Ձևաչափ: | Online Հոդված Տեքստ |
Լեզու: | English |
Հրապարակվել է: |
BioMed Central
2021
|
Խորագրեր: | |
Առցանց հասանելիություն: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350309/ https://www.ncbi.nlm.nih.gov/pubmed/34372769 http://dx.doi.org/10.1186/s12879-021-06494-w |
Նմանատիպ նյութեր
-
Early Fever Resolution in Early Childhood Influenza Treated with Baloxavir Marboxil: A Retrospective Study Compared to Those with Oseltamivir
: Nezu, Keiko, և այլն
Հրապարակվել է: (2023) -
2645. Clinical Outcomes of Oseltamivir vs. Baloxavir in Patients Hospitalized with Influenza A
: Shah, Sunish, և այլն
Հրապարակվել է: (2019) -
922. Cost-effectiveness of baloxavir marboxil versus oseltamivir or no treatment for the management of influenza in the United States
: Hansen, Svenn, և այլն
Հրապարակվել է: (2023) -
Baloxavir Marboxil in Japanese Pediatric Patients With Influenza: Safety and Clinical and Virologic Outcomes
: Hirotsu, Nobuo, և այլն
Հրապարակվել է: (2020) -
1518. Real-World Comparative Effectiveness of Baloxavir Marboxil versus Oseltamivir on Influenza-Related Complication and Resource Utilization
: Neuberger, Eddie, և այլն
Հրապարակվել է: (2020)